Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trialBruno François, Richard S. Hotchkiss, Matthew S. Shotwell et al.|JCI Insight|2018Cited by 412
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in SepsisJacqueline Unsinger, Richard S. Hotchkiss|The Journal of Immunology|2010Cited by 304
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trialThomas Daix, Bruno François, Armelle Mathonnet et al.|Annals of Intensive Care|2023Cited by 76